Uptime Institute Completes Acquisition of CNet Training, the International Award-Winning Technical Education Company
3.2.2023 16:01:00 EET | Business Wire | Press release
Uptime Institute, the Global Digital Infrastructure Authority, a Dominus Capital, L.P. portfolio company, announced today that it has completed its acquisition of Academia Group Limited and all of its global subsidiaries including CNet Training, Ltd.
CNet Training, located in Bury Saint Edmunds, Suffolk, England, is an International award-winning technical education company. CNet Training has been designing and delivering professional network and data center infrastructure training programs since 1996 and has trained over 83,000 data center professionals across 45 countries.
“The data center industry is one of the fastest growing markets in the world. The continued, extraordinary industry expansion requires a growing and diverse workforce, however concerns over the industry’s ability to attract, educate, and retain skilled technical staff persist. This acquisition will help our respective customers thrive in a rapidly changing ecosystem, by giving them access to a range of world class corporate learning and development technical education programs that are backed up by practical experience and specialized domain expertise,” said Martin V. McCarthy, CEO, Uptime Institute.
CNet Training dramatically extends the range and depth of Uptime Education offerings and positions Uptime as the Learning & Development partner of choice around the world. The combined offerings will include solutions valuable for every point in a career for a digital infrastructure professional. This includes entry level staff, even adolescents in apprenticeships, to post graduate degrees in Data Center Leadership for savvy, long serving professionals.
“We are excited to join the accelerating Uptime team. CNet Training was already growing quickly, but now will have many more opportunities through further geographic expansion, and new service offerings, as a part of Uptime. As we look forward to this next phase, I want to personally thank all our clients, staff, and investors who have supported us over these past 26 + years of delivering unique value and in bringing ongoing innovation to the Digital Infrastructure Education market,” said Andrew Stevens, CEO of CNet Training.
Uptime Institute’s Intelligence team recently completed a market research study indicating the number of staff needed to design, build, and operate data centers will continue to grow globally from about 2.0 million in 2019 to nearly 2.3 million by 2025. A wide range of specialist jobs (230 detailed in Uptime Institute Data Center Career Pathfinder, developed in association with Google, Meta & Microsoft) are required by the sector to support its continued expansion. The combination of Uptime Institute and CNet Training will directly address the evolving training needs of all current and future data center employees as they progress through their careers.
Bob Haswell, Founding Partner at Dominus Capital, added, “This first acquisition for Uptime under Dominus ownership will further establish Uptime Education as the unparalleled leader in Digital Infrastructure Education around the world. Uptime is the undisputed market leader worldwide, with results-oriented solutions for both providers and consumers of services delivered through mission critical data center, the true digital foundries, and factories of the Internet economy. The ongoing availability, resiliency, sustainability, security, and business value of these key infrastructure building blocks still overwhelmingly depend on the quality and capabilities of the workforces that operate them, and the skill, training and education of each individual team member.”
Uptime Institute continues to identify and assess potential add-on acquisitions to broaden its offering and continue to execute on its mission to help data center owners, operators, and tenants ensure resilient, available, sustainable, and secure digital infrastructure.
About Uptime Institute
Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.
Uptime Institute is headquartered in New York, NY, with offices in London, Sao Paulo, Dubai, KSA Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.
About CNet Training
CNet Training (CNet) has been delivering technical education programs since 1996. Today CNet is the global leader in technical education for the digital infrastructure industry, comprising the data center and network infrastructure sectors and is the only industry dedicated education provider to award both internationally recognized qualifications and professional certifications. A significant part of CNet Training ’s history is the development of the highly acclaimed Global Digital Infrastructure Education Framework, which offers industry professionals an opportunity to plan technical education, qualifications, and certifications to meet on-going individual and business needs.
Since CNet’s inception it has delivered training across 218 delivery locations in 45 countries and in 19 time zones. Over 83,000 individuals of 153 different nationalities have accessed CNet Training’s technical education. For more information, please visit www.cnet-training.com
About Dominus Capital, L.P.
Based in New York, Dominus Capital is a leading middle-market private equity investment firm focused on management-led buyouts and growth capital investments in family-owned and founder-operated companies in the business services and light manufacturing sectors. Drawing on the experience, knowledge and network of its founders and a team of in-house operating executives, Dominus works hand-in-hand with exceptional management teams to unlock the untapped potential of its portfolio companies. Recently named one of the top 50 middle market private equity firms, Dominus takes a long-term approach to investing and has a consistent and highly successful track record of achieving significant growth at its portfolio companies. The Dominus team has executed more than 90 transactions over the past 20+ years. For more information, please visit www.dominuscap.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230203005099/en/
Contact information
Brenda South, Uptime Institute
bsouth@uptimeinstitute.com
206-706-4647
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
